| Authors: |
Olszewski AJ; Department of Medicine, Brown University, Providence, RI., Avigdor A; Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Babu S; Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN., Levi I; Soroka University Medical Centre, Be'er-Sheva, Israel., Eradat H; Department of Medicine, University of California, Los Angeles, CA., Abadi U; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Meir Medical Center, Kfar Saba, Israel., Holmes H; Texas Oncology/Baylor-Sammons Cancer Center, Dallas, TX., McKinney MS; Department of Medicine, Duke Cancer Institute, Durham, NC., Woszczyk D; Department of Medicine, Institute of Medical Sciences, University of Opole, Opole, Poland., Giannopoulos K; Department of Medicine, Medical University of Lublin, Lublin, Poland., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland., Jing J; Genentech, Inc, South San Francisco, CA., Li D; Roche (China) Holding Ltd, Shanghai, China., Hamidi H; Genentech, Inc, South San Francisco, CA., Penuel E; Genentech, Inc, South San Francisco, CA., Janousek M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wei MC; Genentech, Inc, South San Francisco, CA., Batlevi C; Genentech, Inc, South San Francisco, CA., Ead W; Genentech, Inc, South San Francisco, CA., Sellam G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Horowitz NA; Rambam Health Care Campus, Technion, Haifa, Israel. |
